title: PWZ-029, an inverse agonist selective for α₅ GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats.
abstract: Inverse agonism at the benzodiazepine site of α(5) subunit-containing GABA(A) receptors is an attractive approach for the development of putative cognition-enhancing compounds, which are still far from clinical application. Several ligands with binding and/or functional selectivity for α(5) GABA(A) receptors have been synthesized and tested in a few animal models. PWZ-029 is an α(5) GABA(A) selective inverse agonist whose memory enhancing effects were demonstrated in the passive avoidance task in rats and in Pavlovian fear conditioning in mice. In the present study we investigated the effects of PWZ-029 administration in novel object recognition test and Morris water maze, in normal and scopolamine-treated rats. All the three doses of PWZ-029 (2, 5 and 10 mg/kg) improved object recognition after the 24-h delay period, as shown by significant differences between the exploration times of the novel and old object, and the respective discrimination indices. PWZ-029 (2 mg/kg) also successfully reversed the 0.3 mg/kg scopolamine-induced deficit in recognition memory after the 1-h delay. In the Morris water maze test, PWZ-029 (5, 10 and 15 mg/kg) did not significantly influence swim patterns, either during five acquisition days or during the treatment-free probe trial. PWZ-029 (2, 5 and 10 mg/kg) also proved to be ineffective in the reversal of the 1mg/kg scopolamine-induced memory impairment in the water maze. The present mixed results encourage use of a variety of tests and experimental conditions in order to increase the predictability of preclinical testing of selective α(5) GABA(A) inverse agonists.
authors.affiliation: Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
authors.forename: Marija
authors.initials: M
authors.lastname: Milić
authors.forename: Tamara
authors.initials: T
authors.lastname: Timić
authors.forename: Srđan
authors.initials: S
authors.lastname: Joksimović
authors.forename: Poonam
authors.initials: P
authors.lastname: Biawat
authors.forename: Sundari
authors.initials: S
authors.lastname: Rallapalli
authors.forename: Jovana
authors.initials: J
authors.lastname: Divljaković
authors.forename: Tamara
authors.initials: T
authors.lastname: Radulović
authors.forename: James M
authors.initials: JM
authors.lastname: Cook
authors.forename: Miroslav M
authors.initials: MM
authors.lastname: Savić
mesh_terms: D000818:Animals; D001569:Benzodiazepines / Q000494:pharmacology*; D054314:Drug Inverse Agonism; D058785:GABA-A Receptor Agonists / Q000494:pharmacology*; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects; D011963:Receptors, GABA-A / Q000378:metabolism*; D021641:Recognition, Psychology / Q000187:drug effects*; D012601:Scopolamine / Q000494:pharmacology*
chemical_list: D058785:GABA-A Receptor Agonists; C511535:Gabra5 protein, rat; D018727:Muscarinic Antagonists; C531941:PWZ-029; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D012601:Scopolamine